nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—melanoma—head and neck cancer	0.847	1	CtDrD
Carmustine—Ocular toxicity—Fluorouracil—head and neck cancer	0.00482	0.0464	CcSEcCtD
Carmustine—Effusion—Docetaxel—head and neck cancer	0.00449	0.0432	CcSEcCtD
Carmustine—GSR—Glutathione metabolism—GSTM1—head and neck cancer	0.00328	0.0662	CbGpPWpGaD
Carmustine—Fibrosis—Hydroxyurea—head and neck cancer	0.00317	0.0305	CcSEcCtD
Carmustine—GSR—Glutathione metabolism—GPX1—head and neck cancer	0.00314	0.0634	CbGpPWpGaD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—SOD2—head and neck cancer	0.0029	0.0585	CbGpPWpGaD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—GPX1—head and neck cancer	0.00276	0.0558	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—SOD2—head and neck cancer	0.00266	0.0538	CbGpPWpGaD
Carmustine—Skin necrosis—Hydroxyurea—head and neck cancer	0.00259	0.025	CcSEcCtD
Carmustine—GSR—Oxidative Stress—GPX1—head and neck cancer	0.00254	0.0513	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—CYP1A1—head and neck cancer	0.00251	0.0508	CbGpPWpGaD
Carmustine—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.00239	0.0484	CbGpPWpGaD
Carmustine—Fibrosis—Fluorouracil—head and neck cancer	0.00228	0.022	CcSEcCtD
Carmustine—GSR—Nucleotide metabolism—DPYD—head and neck cancer	0.00219	0.0443	CbGpPWpGaD
Carmustine—Myelosuppression—Vinblastine—head and neck cancer	0.00212	0.0204	CcSEcCtD
Carmustine—Pulmonary fibrosis—Hydroxyurea—head and neck cancer	0.00206	0.0198	CcSEcCtD
Carmustine—Lung infiltration—Hydroxyurea—head and neck cancer	0.00193	0.0186	CcSEcCtD
Carmustine—Myelosuppression—Hydroxyurea—head and neck cancer	0.00193	0.0186	CcSEcCtD
Carmustine—Acute leukaemia—Docetaxel—head and neck cancer	0.00165	0.0159	CcSEcCtD
Carmustine—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.00152	0.0147	CcSEcCtD
Carmustine—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.00151	0.0145	CcSEcCtD
Carmustine—Myelosuppression—Fluorouracil—head and neck cancer	0.00139	0.0134	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—NAT2—head and neck cancer	0.00131	0.0265	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—TGFA—head and neck cancer	0.00129	0.026	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—TYMS—head and neck cancer	0.00125	0.0252	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—GPX1—head and neck cancer	0.00118	0.0239	CbGpPWpGaD
Carmustine—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00117	0.0113	CcSEcCtD
Carmustine—Extravasation—Vinblastine—head and neck cancer	0.00114	0.011	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00113	0.0227	CbGpPWpGaD
Carmustine—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.0011	0.0106	CcSEcCtD
Carmustine—Febrile neutropenia—Fluorouracil—head and neck cancer	0.00108	0.0104	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—GPX1—head and neck cancer	0.00107	0.0217	CbGpPWpGaD
Carmustine—Pulmonary fibrosis—Docetaxel—head and neck cancer	0.00107	0.0103	CcSEcCtD
Carmustine—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00105	0.0211	CbGpPWpGaD
Carmustine—Encephalopathy—Fluorouracil—head and neck cancer	0.00102	0.00979	CcSEcCtD
Carmustine—Myelosuppression—Docetaxel—head and neck cancer	0.001	0.00967	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—CCNA1—head and neck cancer	0.000976	0.0197	CbGpPWpGaD
Carmustine—Neoplasm—Vinblastine—head and neck cancer	0.000898	0.00865	CcSEcCtD
Carmustine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000891	0.018	CbGpPWpGaD
Carmustine—Skin exfoliation—Hydroxyurea—head and neck cancer	0.000865	0.00833	CcSEcCtD
Carmustine—Phlebitis—Vinblastine—head and neck cancer	0.000837	0.00806	CcSEcCtD
Carmustine—Necrosis—Fluorouracil—head and neck cancer	0.000831	0.008	CcSEcCtD
Carmustine—Neoplasm—Hydroxyurea—head and neck cancer	0.000819	0.00789	CcSEcCtD
Carmustine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00081	0.0164	CbGpPWpGaD
Carmustine—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.000792	0.00762	CcSEcCtD
Carmustine—Febrile neutropenia—Docetaxel—head and neck cancer	0.000783	0.00754	CcSEcCtD
Carmustine—Speech disorder—Fluorouracil—head and neck cancer	0.000758	0.0073	CcSEcCtD
Carmustine—Extravasation—Fluorouracil—head and neck cancer	0.000748	0.0072	CcSEcCtD
Carmustine—GSR—NRF2 pathway—GSTM1—head and neck cancer	0.000748	0.0151	CbGpPWpGaD
Carmustine—Oral candidiasis—Docetaxel—head and neck cancer	0.000741	0.00714	CcSEcCtD
Carmustine—Cyst—Docetaxel—head and neck cancer	0.000704	0.00678	CcSEcCtD
Carmustine—Leukocytosis—Fluorouracil—head and neck cancer	0.000694	0.00668	CcSEcCtD
Carmustine—Burning sensation—Docetaxel—head and neck cancer	0.000678	0.00653	CcSEcCtD
Carmustine—Interstitial lung disease—Docetaxel—head and neck cancer	0.000665	0.00641	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—GSTM1—head and neck cancer	0.000647	0.0131	CbGpPWpGaD
Carmustine—Face oedema—Hydroxyurea—head and neck cancer	0.000635	0.00612	CcSEcCtD
Carmustine—GSR—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000632	0.0128	CbGpPWpGaD
Carmustine—Scotoma—Docetaxel—head and neck cancer	0.00062	0.00597	CcSEcCtD
Carmustine—GSR—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000613	0.0124	CbGpPWpGaD
Carmustine—Hepatotoxicity—Docetaxel—head and neck cancer	0.00061	0.00587	CcSEcCtD
Carmustine—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000604	0.0122	CbGpPWpGaD
Carmustine—Necrosis—Docetaxel—head and neck cancer	0.0006	0.00578	CcSEcCtD
Carmustine—Coma—Fluorouracil—head and neck cancer	0.000596	0.00574	CcSEcCtD
Carmustine—Pancytopenia—Vinblastine—head and neck cancer	0.000592	0.0057	CcSEcCtD
Carmustine—Sepsis—Fluorouracil—head and neck cancer	0.000566	0.00545	CcSEcCtD
Carmustine—Depression—Vinblastine—head and neck cancer	0.000554	0.00534	CcSEcCtD
Carmustine—Thrombophlebitis—Fluorouracil—head and neck cancer	0.000547	0.00527	CcSEcCtD
Carmustine—GSR—Metabolism—UROD—head and neck cancer	0.000547	0.011	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000547	0.011	CbGpPWpGaD
Carmustine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000545	0.00525	CcSEcCtD
Carmustine—Pancytopenia—Hydroxyurea—head and neck cancer	0.00054	0.0052	CcSEcCtD
Carmustine—Extravasation—Docetaxel—head and neck cancer	0.00054	0.0052	CcSEcCtD
Carmustine—Swelling—Fluorouracil—head and neck cancer	0.000537	0.00517	CcSEcCtD
Carmustine—Neutropenia—Hydroxyurea—head and neck cancer	0.000532	0.00512	CcSEcCtD
Carmustine—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000511	0.0103	CbGpPWpGaD
Carmustine—Drug interaction—Docetaxel—head and neck cancer	0.000508	0.00489	CcSEcCtD
Carmustine—Amnesia—Fluorouracil—head and neck cancer	0.000504	0.00485	CcSEcCtD
Carmustine—Haemoglobin—Vinblastine—head and neck cancer	0.000502	0.00483	CcSEcCtD
Carmustine—Haemorrhage—Vinblastine—head and neck cancer	0.000499	0.00481	CcSEcCtD
Carmustine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000497	0.00479	CcSEcCtD
Carmustine—Hypoaesthesia—Vinblastine—head and neck cancer	0.000497	0.00478	CcSEcCtD
Carmustine—Stomatitis—Hydroxyurea—head and neck cancer	0.000494	0.00476	CcSEcCtD
Carmustine—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000491	0.00992	CbGpPWpGaD
Carmustine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000474	0.00456	CcSEcCtD
Carmustine—Pulmonary embolism—Docetaxel—head and neck cancer	0.000471	0.00453	CcSEcCtD
Carmustine—Injection site reaction—Docetaxel—head and neck cancer	0.000468	0.00451	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—SOD2—head and neck cancer	0.000467	0.00944	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000466	0.0094	CbGpPWpGaD
Carmustine—Haemoglobin—Hydroxyurea—head and neck cancer	0.000457	0.00441	CcSEcCtD
Carmustine—Haemorrhage—Hydroxyurea—head and neck cancer	0.000455	0.00438	CcSEcCtD
Carmustine—Hallucination—Hydroxyurea—head and neck cancer	0.000453	0.00436	CcSEcCtD
Carmustine—Skin exfoliation—Docetaxel—head and neck cancer	0.00045	0.00433	CcSEcCtD
Carmustine—Candida infection—Docetaxel—head and neck cancer	0.00045	0.00433	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—GPX1—head and neck cancer	0.000446	0.009	CbGpPWpGaD
Carmustine—Ataxia—Fluorouracil—head and neck cancer	0.000445	0.00429	CcSEcCtD
Carmustine—Neuropathy—Docetaxel—head and neck cancer	0.000442	0.00426	CcSEcCtD
Carmustine—Alopecia—Vinblastine—head and neck cancer	0.000441	0.00425	CcSEcCtD
Carmustine—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000428	0.00864	CbGpPWpGaD
Carmustine—Neoplasm—Docetaxel—head and neck cancer	0.000426	0.0041	CcSEcCtD
Carmustine—Muscular weakness—Fluorouracil—head and neck cancer	0.000418	0.00402	CcSEcCtD
Carmustine—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000411	0.00831	CbGpPWpGaD
Carmustine—Dysphagia—Fluorouracil—head and neck cancer	0.000409	0.00394	CcSEcCtD
Carmustine—Sepsis—Docetaxel—head and neck cancer	0.000409	0.00393	CcSEcCtD
Carmustine—Alopecia—Hydroxyurea—head and neck cancer	0.000402	0.00387	CcSEcCtD
Carmustine—Anaemia—Vinblastine—head and neck cancer	0.000402	0.00387	CcSEcCtD
Carmustine—Phlebitis—Docetaxel—head and neck cancer	0.000397	0.00382	CcSEcCtD
Carmustine—Erythema—Hydroxyurea—head and neck cancer	0.000396	0.00382	CcSEcCtD
Carmustine—Thrombophlebitis—Docetaxel—head and neck cancer	0.000395	0.0038	CcSEcCtD
Carmustine—Leukopenia—Vinblastine—head and neck cancer	0.000389	0.00374	CcSEcCtD
Carmustine—Pancytopenia—Fluorouracil—head and neck cancer	0.000389	0.00374	CcSEcCtD
Carmustine—Swelling—Docetaxel—head and neck cancer	0.000387	0.00373	CcSEcCtD
Carmustine—Convulsion—Vinblastine—head and neck cancer	0.000376	0.00362	CcSEcCtD
Carmustine—Hypertension—Vinblastine—head and neck cancer	0.000375	0.00361	CcSEcCtD
Carmustine—Pneumonia—Fluorouracil—head and neck cancer	0.000367	0.00353	CcSEcCtD
Carmustine—Anaemia—Hydroxyurea—head and neck cancer	0.000366	0.00353	CcSEcCtD
Carmustine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000358	0.00344	CcSEcCtD
Carmustine—Stomatitis—Fluorouracil—head and neck cancer	0.000356	0.00343	CcSEcCtD
Carmustine—Urinary tract infection—Fluorouracil—head and neck cancer	0.000355	0.00342	CcSEcCtD
Carmustine—Leukopenia—Hydroxyurea—head and neck cancer	0.000355	0.00342	CcSEcCtD
Carmustine—Thrombocytopenia—Vinblastine—head and neck cancer	0.000347	0.00334	CcSEcCtD
Carmustine—Convulsion—Hydroxyurea—head and neck cancer	0.000343	0.00331	CcSEcCtD
Carmustine—Hyponatraemia—Docetaxel—head and neck cancer	0.000343	0.0033	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000342	0.00329	CcSEcCtD
Carmustine—Anorexia—Vinblastine—head and neck cancer	0.000338	0.00325	CcSEcCtD
Carmustine—Haemoglobin—Fluorouracil—head and neck cancer	0.000329	0.00317	CcSEcCtD
Carmustine—Haemorrhage—Fluorouracil—head and neck cancer	0.000328	0.00315	CcSEcCtD
Carmustine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000326	0.00314	CcSEcCtD
Carmustine—Oedema—Hydroxyurea—head and neck cancer	0.000323	0.00311	CcSEcCtD
Carmustine—Ataxia—Docetaxel—head and neck cancer	0.000321	0.00309	CcSEcCtD
Carmustine—Infection—Hydroxyurea—head and neck cancer	0.000321	0.00309	CcSEcCtD
Carmustine—Paraesthesia—Vinblastine—head and neck cancer	0.000318	0.00307	CcSEcCtD
Carmustine—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000318	0.00642	CbGpPWpGaD
Carmustine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000317	0.00305	CcSEcCtD
Carmustine—Liver function test abnormal—Docetaxel—head and neck cancer	0.000316	0.00304	CcSEcCtD
Carmustine—Anorexia—Hydroxyurea—head and neck cancer	0.000308	0.00297	CcSEcCtD
Carmustine—Decreased appetite—Vinblastine—head and neck cancer	0.000308	0.00297	CcSEcCtD
Carmustine—Pain—Vinblastine—head and neck cancer	0.000303	0.00292	CcSEcCtD
Carmustine—Constipation—Vinblastine—head and neck cancer	0.000303	0.00292	CcSEcCtD
Carmustine—Dysphagia—Docetaxel—head and neck cancer	0.000295	0.00284	CcSEcCtD
Carmustine—Arrhythmia—Fluorouracil—head and neck cancer	0.000293	0.00282	CcSEcCtD
Carmustine—Feeling abnormal—Vinblastine—head and neck cancer	0.000292	0.00281	CcSEcCtD
Carmustine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00029	0.00279	CcSEcCtD
Carmustine—Alopecia—Fluorouracil—head and neck cancer	0.000289	0.00279	CcSEcCtD
Carmustine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000288	0.00278	CcSEcCtD
Carmustine—Somnolence—Hydroxyurea—head and neck cancer	0.000287	0.00277	CcSEcCtD
Carmustine—Erythema—Fluorouracil—head and neck cancer	0.000285	0.00275	CcSEcCtD
Carmustine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000281	0.00271	CcSEcCtD
Carmustine—Pancytopenia—Docetaxel—head and neck cancer	0.000281	0.0027	CcSEcCtD
Carmustine—Abdominal pain—Vinblastine—head and neck cancer	0.00028	0.0027	CcSEcCtD
Carmustine—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.00028	0.00566	CbGpPWpGaD
Carmustine—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000279	0.00564	CbGpPWpGaD
Carmustine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000279	0.00269	CcSEcCtD
Carmustine—Constipation—Hydroxyurea—head and neck cancer	0.000276	0.00266	CcSEcCtD
Carmustine—Pain—Hydroxyurea—head and neck cancer	0.000276	0.00266	CcSEcCtD
Carmustine—Neutropenia—Docetaxel—head and neck cancer	0.000276	0.00266	CcSEcCtD
Carmustine—Vision blurred—Fluorouracil—head and neck cancer	0.000269	0.00259	CcSEcCtD
Carmustine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000266	0.00257	CcSEcCtD
Carmustine—Pneumonia—Docetaxel—head and neck cancer	0.000265	0.00255	CcSEcCtD
Carmustine—Anaemia—Fluorouracil—head and neck cancer	0.000264	0.00254	CcSEcCtD
Carmustine—Hypersensitivity—Vinblastine—head and neck cancer	0.000261	0.00252	CcSEcCtD
Carmustine—Renal failure—Docetaxel—head and neck cancer	0.000259	0.00249	CcSEcCtD
Carmustine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000258	0.00249	CcSEcCtD
Carmustine—Stomatitis—Docetaxel—head and neck cancer	0.000257	0.00247	CcSEcCtD
Carmustine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000256	0.00246	CcSEcCtD
Carmustine—Leukopenia—Fluorouracil—head and neck cancer	0.000255	0.00246	CcSEcCtD
Carmustine—Asthenia—Vinblastine—head and neck cancer	0.000254	0.00245	CcSEcCtD
Carmustine—Convulsion—Fluorouracil—head and neck cancer	0.000247	0.00238	CcSEcCtD
Carmustine—Chest pain—Fluorouracil—head and neck cancer	0.000243	0.00234	CcSEcCtD
Carmustine—Myalgia—Fluorouracil—head and neck cancer	0.000243	0.00234	CcSEcCtD
Carmustine—Diarrhoea—Vinblastine—head and neck cancer	0.000243	0.00234	CcSEcCtD
Carmustine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000238	0.00229	CcSEcCtD
Carmustine—Haemoglobin—Docetaxel—head and neck cancer	0.000238	0.00229	CcSEcCtD
Carmustine—Haemorrhage—Docetaxel—head and neck cancer	0.000236	0.00228	CcSEcCtD
Carmustine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000235	0.00227	CcSEcCtD
Carmustine—Confusional state—Fluorouracil—head and neck cancer	0.000235	0.00226	CcSEcCtD
Carmustine—Dizziness—Vinblastine—head and neck cancer	0.000234	0.00226	CcSEcCtD
Carmustine—Oedema peripheral—Docetaxel—head and neck cancer	0.000233	0.00224	CcSEcCtD
Carmustine—Oedema—Fluorouracil—head and neck cancer	0.000233	0.00224	CcSEcCtD
Carmustine—Connective tissue disorder—Docetaxel—head and neck cancer	0.000232	0.00224	CcSEcCtD
Carmustine—Asthenia—Hydroxyurea—head and neck cancer	0.000232	0.00223	CcSEcCtD
Carmustine—Infection—Fluorouracil—head and neck cancer	0.000231	0.00223	CcSEcCtD
Carmustine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000228	0.00219	CcSEcCtD
Carmustine—Visual impairment—Docetaxel—head and neck cancer	0.000228	0.00219	CcSEcCtD
Carmustine—Tachycardia—Fluorouracil—head and neck cancer	0.000227	0.00219	CcSEcCtD
Carmustine—GSR—Metabolism—NAT2—head and neck cancer	0.000227	0.00459	CbGpPWpGaD
Carmustine—Vomiting—Vinblastine—head and neck cancer	0.000225	0.00217	CcSEcCtD
Carmustine—Headache—Vinblastine—head and neck cancer	0.000222	0.00214	CcSEcCtD
Carmustine—Anorexia—Fluorouracil—head and neck cancer	0.000222	0.00214	CcSEcCtD
Carmustine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000221	0.00213	CcSEcCtD
Carmustine—Eye disorder—Docetaxel—head and neck cancer	0.000221	0.00213	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.00022	0.00444	CbGpPWpGaD
Carmustine—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00022	0.00444	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.00022	0.00444	CbGpPWpGaD
Carmustine—Flushing—Docetaxel—head and neck cancer	0.000219	0.00211	CcSEcCtD
Carmustine—Hypotension—Fluorouracil—head and neck cancer	0.000217	0.00209	CcSEcCtD
Carmustine—Dizziness—Hydroxyurea—head and neck cancer	0.000214	0.00206	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000212	0.00204	CcSEcCtD
Carmustine—Arrhythmia—Docetaxel—head and neck cancer	0.000211	0.00203	CcSEcCtD
Carmustine—Nausea—Vinblastine—head and neck cancer	0.000211	0.00203	CcSEcCtD
Carmustine—Insomnia—Fluorouracil—head and neck cancer	0.00021	0.00203	CcSEcCtD
Carmustine—Paraesthesia—Fluorouracil—head and neck cancer	0.000209	0.00201	CcSEcCtD
Carmustine—Alopecia—Docetaxel—head and neck cancer	0.000209	0.00201	CcSEcCtD
Carmustine—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000208	0.00419	CbGpPWpGaD
Carmustine—Dyspnoea—Fluorouracil—head and neck cancer	0.000207	0.002	CcSEcCtD
Carmustine—Mental disorder—Docetaxel—head and neck cancer	0.000207	0.00199	CcSEcCtD
Carmustine—Somnolence—Fluorouracil—head and neck cancer	0.000207	0.00199	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—VEGFA—head and neck cancer	0.000207	0.00418	CbGpPWpGaD
Carmustine—Malnutrition—Docetaxel—head and neck cancer	0.000206	0.00198	CcSEcCtD
Carmustine—Erythema—Docetaxel—head and neck cancer	0.000206	0.00198	CcSEcCtD
Carmustine—Vomiting—Hydroxyurea—head and neck cancer	0.000206	0.00198	CcSEcCtD
Carmustine—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000206	0.00415	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—STAT3—head and neck cancer	0.000205	0.00413	CbGpPWpGaD
Carmustine—Rash—Hydroxyurea—head and neck cancer	0.000204	0.00196	CcSEcCtD
Carmustine—Dermatitis—Hydroxyurea—head and neck cancer	0.000204	0.00196	CcSEcCtD
Carmustine—Headache—Hydroxyurea—head and neck cancer	0.000203	0.00195	CcSEcCtD
Carmustine—Decreased appetite—Fluorouracil—head and neck cancer	0.000202	0.00195	CcSEcCtD
Carmustine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000201	0.00194	CcSEcCtD
Carmustine—GSR—Metabolism—DPYD—head and neck cancer	0.000199	0.00402	CbGpPWpGaD
Carmustine—Back pain—Docetaxel—head and neck cancer	0.000199	0.00192	CcSEcCtD
Carmustine—Pain—Fluorouracil—head and neck cancer	0.000199	0.00192	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—MAPK3—head and neck cancer	0.000196	0.00395	CbGpPWpGaD
Carmustine—Nausea—Hydroxyurea—head and neck cancer	0.000192	0.00185	CcSEcCtD
Carmustine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000192	0.00185	CcSEcCtD
Carmustine—Anaemia—Docetaxel—head and neck cancer	0.00019	0.00183	CcSEcCtD
Carmustine—GSR—Metabolism—YAP1—head and neck cancer	0.000189	0.00382	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—MAPK1—head and neck cancer	0.000186	0.00376	CbGpPWpGaD
Carmustine—Leukopenia—Docetaxel—head and neck cancer	0.000184	0.00177	CcSEcCtD
Carmustine—Body temperature increased—Fluorouracil—head and neck cancer	0.000184	0.00177	CcSEcCtD
Carmustine—Convulsion—Docetaxel—head and neck cancer	0.000178	0.00172	CcSEcCtD
Carmustine—Hypertension—Docetaxel—head and neck cancer	0.000178	0.00171	CcSEcCtD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000178	0.00359	CbGpPWpGaD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000175	0.00354	CbGpPWpGaD
Carmustine—Myalgia—Docetaxel—head and neck cancer	0.000175	0.00169	CcSEcCtD
Carmustine—Chest pain—Docetaxel—head and neck cancer	0.000175	0.00169	CcSEcCtD
Carmustine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000171	0.00165	CcSEcCtD
Carmustine—Confusional state—Docetaxel—head and neck cancer	0.000169	0.00163	CcSEcCtD
Carmustine—Oedema—Docetaxel—head and neck cancer	0.000168	0.00162	CcSEcCtD
Carmustine—Infection—Docetaxel—head and neck cancer	0.000167	0.00161	CcSEcCtD
Carmustine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000164	0.00158	CcSEcCtD
Carmustine—Tachycardia—Docetaxel—head and neck cancer	0.000164	0.00158	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000163	0.0033	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000161	0.00326	CbGpPWpGaD
Carmustine—Anorexia—Docetaxel—head and neck cancer	0.00016	0.00154	CcSEcCtD
Carmustine—Diarrhoea—Fluorouracil—head and neck cancer	0.000159	0.00153	CcSEcCtD
Carmustine—Hypotension—Docetaxel—head and neck cancer	0.000157	0.00151	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—TP53—head and neck cancer	0.000156	0.00315	CbGpPWpGaD
Carmustine—Dizziness—Fluorouracil—head and neck cancer	0.000154	0.00148	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000153	0.00147	CcSEcCtD
Carmustine—Insomnia—Docetaxel—head and neck cancer	0.000152	0.00146	CcSEcCtD
Carmustine—Paraesthesia—Docetaxel—head and neck cancer	0.000151	0.00145	CcSEcCtD
Carmustine—Dyspnoea—Docetaxel—head and neck cancer	0.00015	0.00144	CcSEcCtD
Carmustine—Somnolence—Docetaxel—head and neck cancer	0.000149	0.00144	CcSEcCtD
Carmustine—Vomiting—Fluorouracil—head and neck cancer	0.000148	0.00143	CcSEcCtD
Carmustine—Rash—Fluorouracil—head and neck cancer	0.000147	0.00141	CcSEcCtD
Carmustine—Dermatitis—Fluorouracil—head and neck cancer	0.000147	0.00141	CcSEcCtD
Carmustine—Decreased appetite—Docetaxel—head and neck cancer	0.000146	0.00141	CcSEcCtD
Carmustine—Headache—Fluorouracil—head and neck cancer	0.000146	0.0014	CcSEcCtD
Carmustine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000145	0.0014	CcSEcCtD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000144	0.00291	CbGpPWpGaD
Carmustine—Constipation—Docetaxel—head and neck cancer	0.000144	0.00138	CcSEcCtD
Carmustine—Pain—Docetaxel—head and neck cancer	0.000144	0.00138	CcSEcCtD
Carmustine—Feeling abnormal—Docetaxel—head and neck cancer	0.000138	0.00133	CcSEcCtD
Carmustine—Nausea—Fluorouracil—head and neck cancer	0.000138	0.00133	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000138	0.00279	CbGpPWpGaD
Carmustine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000137	0.00132	CcSEcCtD
Carmustine—Body temperature increased—Docetaxel—head and neck cancer	0.000133	0.00128	CcSEcCtD
Carmustine—Abdominal pain—Docetaxel—head and neck cancer	0.000133	0.00128	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000131	0.00264	CbGpPWpGaD
Carmustine—Hypersensitivity—Docetaxel—head and neck cancer	0.000124	0.00119	CcSEcCtD
Carmustine—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000122	0.00247	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000121	0.00245	CbGpPWpGaD
Carmustine—Asthenia—Docetaxel—head and neck cancer	0.000121	0.00116	CcSEcCtD
Carmustine—Diarrhoea—Docetaxel—head and neck cancer	0.000115	0.00111	CcSEcCtD
Carmustine—GSR—Metabolism—TYMS—head and neck cancer	0.000113	0.00229	CbGpPWpGaD
Carmustine—GSR—Metabolism—GSTM1—head and neck cancer	0.000112	0.00227	CbGpPWpGaD
Carmustine—Dizziness—Docetaxel—head and neck cancer	0.000111	0.00107	CcSEcCtD
Carmustine—GSR—Metabolism—GPX1—head and neck cancer	0.000107	0.00217	CbGpPWpGaD
Carmustine—Vomiting—Docetaxel—head and neck cancer	0.000107	0.00103	CcSEcCtD
Carmustine—GSR—Metabolism—CYP1A1—head and neck cancer	0.000106	0.00215	CbGpPWpGaD
Carmustine—Rash—Docetaxel—head and neck cancer	0.000106	0.00102	CcSEcCtD
Carmustine—Dermatitis—Docetaxel—head and neck cancer	0.000106	0.00102	CcSEcCtD
Carmustine—Headache—Docetaxel—head and neck cancer	0.000105	0.00101	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000103	0.00208	CbGpPWpGaD
Carmustine—Nausea—Docetaxel—head and neck cancer	9.98e-05	0.000961	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	9.27e-05	0.00187	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	9.26e-05	0.00187	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	9.26e-05	0.00187	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	8.07e-05	0.00163	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	7.96e-05	0.00161	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	7.65e-05	0.00155	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	7.55e-05	0.00152	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	7.44e-05	0.0015	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—UROD—head and neck cancer	6.73e-05	0.00136	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTGS2—head and neck cancer	6.32e-05	0.00128	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTEN—head and neck cancer	5.51e-05	0.00111	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.22e-05	0.00105	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CA—head and neck cancer	3.89e-05	0.000786	CbGpPWpGaD
Carmustine—GSR—Metabolism—AKT1—head and neck cancer	3.18e-05	0.000642	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.97e-05	0.0006	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.94e-05	0.000593	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NAT2—head and neck cancer	2.79e-05	0.000564	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—DPYD—head and neck cancer	2.45e-05	0.000495	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—YAP1—head and neck cancer	2.33e-05	0.00047	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.75e-05	0.000353	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.52e-05	0.000308	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TYMS—head and neck cancer	1.4e-05	0.000282	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.38e-05	0.000279	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GPX1—head and neck cancer	1.32e-05	0.000267	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.31e-05	0.000264	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.07e-05	0.000217	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTGS2—head and neck cancer	7.78e-06	0.000157	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTEN—head and neck cancer	6.79e-06	0.000137	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	4.79e-06	9.67e-05	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKT1—head and neck cancer	3.91e-06	7.9e-05	CbGpPWpGaD
